{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-22-002702","form_type":"8-K","ticker":"BICX","cik":"0001443863","company_name":"BioCorRx Inc.","filed_at":"2022-04-28T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.747490+00:00","generated_at":"2026-06-26T03:20:23.331876+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"BioCorRx adopts 2022 Omnibus Plan authorizing 695,000 shares for equity incentives","bullets":["Board approved 2022 Omnibus Securities and Incentive Plan on April 22, 2022; replaces 2018 plan.","Plan reserves 695,000 shares of common stock for future equity awards.","Non-employee director annual compensation cap set at $300,000 (equity + cash).","Outstanding 2018 plan awards continue; forfeited shares become available under 2022 plan.","Plan permits options, restricted stock, units, performance units, SARs and distribution equivalent rights."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-22-002702","json":"https://secwatch.observer/filing/0001477932-22-002702.json","markdown":"https://secwatch.observer/filing/0001477932-22-002702.md","text":"https://secwatch.observer/filing/0001477932-22-002702.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222002702/0001477932-22-002702-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1443863/000147793222002702/bicx_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T03:20:23.331876+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}